Dr. Xiang Yang Zhang is an Associate Professor, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, USA. His studies in cognition, biomarkers including oxidative stress, neuroimaging, genetics and clinical psychopharmacology in schizophrenia and addiction research.
Dr. Jan Copeland is the Founding Director of the National Cannabis Prevention and Information Centre (NCPIC), University of New South Wales, Australia. She has worked in the addictions including women’s treatment, monitoring systems for treatment outcome and best known for her studies developing and testing brief interventions for the management of cannabis use disorder among adults.
Dr. Daryl Davies is the Director of the Alcohol and Brain Research Laboratories and Associate Professor at the University of Southern California, School of Pharmacy, USA. His research includes identification of molecular mechanisms and targets of ethanol action and the discovery and development of new drugs that can be used for the prevention and/or treatment of alcohol use disorders.
Dr. Pier Paolo Pani is the Director of the Social Health Services and past Medical Responsible of the Addiction Service, Health Public Trust of Cagliari, Italy. He is an active researcher in the field of addictive disorders with focus on psychopathology of addiction and efficacy of pharmacological and integrated treatments.
Dr. John Dani is the Director of the Center on Addiction, Learning, Memory in the Department of Neuroscience at Baylor College of Medicine, USA. His research interests focuses on cocaine, alcohol, and nicotine addiction and has produced convincing evidence that addictive drugs induce synaptic plasticity.
Dr. Philip Holmes is Chair of the Neuroscience Program and Professor in the Psychology Department, University of Georgia, USA. His research focuses on behavioral neuropharmacology and neuropeptide modulation of monoamines in rodent models of anxiety and addiction. His work also examines the role of trophic factor-mediated plasticity in resistance to stress and drug seeking behavior.
Dr. Horace Loh is a Regents Professor, Frederick Stark Professor and Chair of the Department of Pharmacology, University of Minnesota, USA. His research focuses in molecular neurobiology of opioid actions and addiction. His detailed studies are in opioid receptor signaling, regulation of receptor activity, receptor gene cloning and receptor gene regulation and the pharmacology of endorphins.
Dr. Linda B. Cottler is a Dean’s Professor and Chair of the Department of Epidemiology at the University of Florida, USA. Her research interest includes developing assessments of addiction and mental health and community-based interventions to reduce high-risk behaviors.
Dr. Patrick Sullivan is a Professor at the Indiana University School of Social Work, USA. He also serves as a steering committee member for the SAMHSA/CSWE Recovery to Practice project. His area of research includes mental health, addictions, and strengths-based practice.
Dr. Josephine Johns is a Professor in the Department of Psychiatry and Adjunct Professor of Psychology, at the University of North Carolina at Chapel Hill, USA. Her NIH-funded research programs focus on the impact of drugs of abuse, particularly cocaine on maternal and infant behavior and infant development with a focus on translational research.
Dr. Cheng Ji is a Professor of Research Medicine at the Keck School of Medicine of University of Southern California (USC), USA. His research interests include studying pathogenic mechanisms of alcohol-induced organelle stress and organ injury and developing highly efficient enzyme nanocomplexes of alcohol or drug metabolism for dealing with alcohol intoxication or drug overdose.
Dr. Dorit Ron is a Professor in the Department of Neurology at University of California, San Francisco, USA. She is also the Endowed Chair in Cell Biology of Addiction in Neurology at UCSF, the Director of Intramural Programs at the Gallo Research Center and the Scientific Director for a P50 NIH-NIAAA center grant. Her research focuses on the molecular neurobiology of addiction.
Dr. Christine Horrocks is a Professor of Applied Social Psychology at Manchester Metropolitan University, England. Her research includes collaboration with the probation service investigating coercive treatment interventions for drug and alcohol misuse and monitoring and evaluation of community based health interventions.
Dr. Frances Levin is a Professor of Clinical Psychiatry at Columbia University and Director of the Addiction Psychiatry Fellowship Program at New York Presbyterian Hospital, USA. Her research interests include pharmacologic and psychotherapeutic treatment interventions for cocaine and marijuana abuse, and treatment approaches for substance abusers with attention-deficit hyperactivity disorder.
Dr. Steven L. Youngentob is a Professor of Psychiatry and Behavioral Sciences at the State University of New York, Upstate Medical University, USA. His research focuses on how fetal and adolescent alcohol exposure alters the development of the smell, taste and oro-somatosensory systems so that the normally aversive odor and flavor qualities of alcohol become more acceptable thereby enhancing adolescent intake.
Dr. Hedayet Chowdhury is a Professor in the School of Business at Humber and Centennial College, Toronto, Ontario. His research focuses on the performance evaluation of health care providers in the context of publicly funded health care. He is currently involved with a number of projects on productive efficiency of health care services.
Dr. Chitra Mandyam is an Associate Professor of Committee on the Neurobiology of Addictive Disorders at The Scripps Research Institute, USA. Her research focuses on the relationship between brain structure and function using state-of-the-art molecular and cellular approaches to study high-level mental functions such as drug taking and seeking.
Dr. Won Kim Cook is an Associate Scientist at the Alcohol Research Group, Public Health Institute, USA. Her research areas include alcohol use and health access issues in Asian American communities. Currently she is the Principal Investigator of a research project on adolescent and young adult drinking funded by the National Institute on Alcohol Abuse and Alcoholism.
Dr. Lindsay Ham is an Associate Professor in the Department of Psychological Science at the University of Arkansas, USA. Her research emphasizes on the interplay between substance use behaviors and anxiety, including threat cue processing. She has also established a line of research examining the factors associated with college student drinking.
Dr. Rita Fuchs is an Associate Professor in the Department of Psychology, with joint appointments in the Curriculum in Neurobiology and the Neuroscience Center, at the University of North Carolina at Chapel Hill, USA. Her NIH-funded research programs focus on the impact of drug-associated environmental stimuli on motivated behavior, cognitive function, and physiology.
Dr. Michael MacLean is an Associate Professor of Psychology, SUNY Buffalo State, USA. His NIH and SAMHSA funded research focuses on risk and protective factors associated with substance misuse and related problems among college students. He is also involved in developing, implementing and evaluating brief interventions for adolescents and young adults experiencing problems related to substance misuse.
Dr. M Behnam Ghasemzadeh is an Associate Professor in the Department of Biomedical Sciences and a member of the Integrative Neuroscience Research Center, at Marquette University in Milwaukee, Wisconsin, USA. His research programs focus on the molecular and cellular mechanisms of drug abuse, mental disorders, and synaptic plasticity.
Dr. Xianghua Luo is an Associate Professor in the Division of Biostatistics, School of Public Health, University of Minnesota, USA. Her research interests include development and application of methods for recurrent event data, survival data, longitudinal data and design and analysis of clinical trials. Her collaborations focus on tobacco research, cancer research, and blood and marrow transplant (BMT).
Dr. Peralta is an Associate Professor of Sociology at the University of Akron, USA. His research focuses on association between gender orientation and substance abuse behavior to inform and enhance substance use prevention, treatment and interventions targeting at-risk adolescents, college students, and young adults.
Dr. Bart Ellenbroek is an Associate Professor at Victoria University Wellington, New Zealand School of Psychology, New Zealand. His research focuses on the long term consequences of gene & environment interactions on both behaviour and neurochemistry. In addition, he is interested in the co-morbidity between drug addiction and other psychiatric disorders, especially schizophrenia and autism.
Dr. Ramon Oscar Bernabeu is an Associate Professor of Institute of Cell Biology and Neuroscience and Department of Physiology, School of Medicine, at University of Buenos Aires, Argentina. His research interest focuses on Drug Addiction, Nicotine and mammals nervous system.
Dr. David Nielsen is an Associate Professor of Psychiatry and Behavioral Science at the Baylor College of Medicine, USA. His primary research focus is on understanding the genetics and epigenetics of inter-individual differences that modulate psychostimulant addiction therapeutic response, vulnerability to develop cocaine and nicotine addiction, and recovery from traumatic brain injury.
Dr. Regine Haardörfer is a Research Assistant Professor in the Department of Behavioral Sciences and Health at the Rollins School of Public Health of Emory University, USA. Her research interests include multilevel modeling as well as intervention studies to foster healthy behaviors.
Dr. Habibeh Khoshbouei is an Associate Professor in the Department of Neuroscience at University of Florida, College of Medicine, USA. Her research is to understand how the dopamine transporter (DAT) regulates biological responses, and how this regulation is modulated by structural differences in ligands acting at DAT and by DAT-interacting proteins such as alpha-synuclein and Sigma-1Receptor.
Dr. Francesca Filbey is an Associate Professor and Director of Addiction Studies, Center for Brain Health, School of Behavioral and Brain Sciences at the University of Texas, Dallas, USA. Her research interest focuses on combining neuroimaging and genetic techniques to characterize neural mechanisms associated with addictive disorders.
Dr. Linda Haddad is an Associate Professor of Community Health Nursing and a Research Fellow, Institute for Drug and Alcohol Studies, Virginia Commonwealth University, USA. Her interest has focused on tobacco smoking among disparity groups in both US & Middle East. Her current research focuses on developing smoking cessation tailored to minority groups living in Mid-Atlantic region.
Dr. Roberto Maniglio is an Associate Professor of Clinical Psychology,University of Salento, Italy. He is a psychotherapist, a criminologist and forensic psychopathologist, and a court-appointed expert. His research interests include the etiology and prevalence of psychiatric disorders, family dysfunction, parenting, intimate partner violence, child abuse, sexual crimes, victimization, and aggression.
Dr. Reid S.Alisch is an Assistant Professor, Department of Psychiatry, University of Wisconsin School of Medicine, USA. His research focuses on the role of epigenetics in human health and disease. In his lab, they utilize murine and non-human primate model systems to investigate the dynamics of DNA methylation in response to early life stress, which contribute to neurodevelopmental health & disease states.
Dr. Joseph Kang is an Assistant Professor, Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, USA. His research focuses on biostatistical and epidemiological methodologies for observational studies and missing data that investigate effects of multiple healthy/unhealthy behaviors on adolescent & childhood obesity, cardiovascular diseases, cancer & Tobacco Control.
Dr. Mei Qiang is an Assistant Professor in the Department of Pharmacology at the University of Texas Health Science Center at San Antonio, USA. Her research focus on the epigenetic mechanisms of neuroadaptation associated to alcohol addiction, especially, the regulatory role of alcohol on NMDA receptor’s expression and epigenetic modifications.
Dr. Marc Copersino is an Assistant Professor of Psychology at Harvard Medical School, USA. His research focuses on the evaluation and treatment of substance dependent and dually-diagnosed patients integrating methods of complementary cognitive psychology, neuropsychology, and neuroimaging.
Dr. Rajendra Badgaiyan completed residency training in Psychiatry at Harvard Medical School, UK. He has also obtained Master’s degree in Psychology and has completed postdoctoral training in cognitive neuroscience and neuroimaging. Currently he is in the faculty of Harvard University and University at Buffalo where he is the Director of Neuroimaging and Molecular Imaging Laboratory.
Dr. Raymond Booth is a Medicinal Chemist and Neuropharmacologist. He directs an NIH funded research laboratory at the Northeastern University Center for Drug Discovery in Boston, Massachusetts, USA. His lab is engaged in drug discovery and development for treatment of neuropsychiatric disorders, including, psychoses, addiction (drugs, alcohol, nicotine, food), and attention related disorders (ADHD).
Dr. Jean Gehricke is an Assistant Professor, Department of Pediatrics, University of California, Irvine, USA. He is a licensed psychologist and specializes in drug abuse treatment and prevention in ADHD and other neurodevelopmental disorders. His lab is funded by NIH and focuses on the underlying mechanisms of drug abuse, in particular tobacco and marijuana use in at risk youth and young adult populations.
Dr. Konstantin Voronin is an Assistant Professor, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, USA. His research focuses on psychopharmacology and psychopathology of alcoholism and drug addiction, as well as on pharmacogenetics of these diseases. He also investigates new methods of treatment and prevention in drug addiction field.
Dr. Ayman Fareed is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Emory University, USA. He is a national mentor for buprenorphine treatment, a program funded by Substance Abuse and Mental Health Service Administration . He has several publications focused on the area of health promotion and treatment outcome for opioid agonist therapy.
Dr. Gang Lu is an Assistant Professor in Translational Research Team in Division of Neurosurgery, and Stem Cell and Regenerative Theme of School of Biomedical Sciences in the Chinese University of Hong Kong, China. His research interesting is neural regenerative medicine including drug addiction and stem conversion for clinical application.
Dr. Rong Chen is an Assistant Professor, Department of Physiology and Pharmacology, Wake Forest University School of Medicine, USA. Her research focuses on understanding the molecular and cellular mechanisms underlying psychostimulant addiction in animal models, particularly amphetamine and cocaine abuse, neural stem therapy for neuropsychiatric and neurodegenerative diseases.
Dr. Barbara Oswald is an Assistant Professor in the Department of Psychology at Miami University, Hamilton, USA. Her research interests are Neurobiology of Learning and Memory, Behavioral Pharmacology and Neuropharmacology, Addiction in animals and people, Cognitive Enhancement/Reversal of Cognitive Deficits and Stimulus properties of CNS stimulant, hallucinogenic and related drugs.
Dr. Xiaohu Xie is an Assistant Professor in the Department of Chemistry at the North Carolina State University, USA. His research focused on investigating the molecular, neuropharmacological, and neurochemical mechanisms of drug addiction, decision making, and social interaction.
Dr. Marcelo Febo is an Assistant Professor of Psychiatry at the University of Florida and Program Director of Translational Research Imaging in the McKnight Brain Institute, USA. His research focuses on understanding the neural mechanisms of addiction, reward and neurodegenerative diseases.
Dr. Marek Schwendt is a Research Assistant Professor in the Department of Psychology at the University of Florida, USA. He is using translational animal models of cocaine and methamphetamine addiction to study neurobiological mechanisms underlying persistent relapse vulnerability and cognitive deficits in drug addiction.
Dr. Daniel McGrath is an Assistant Professor in the Department of Psychology at Mount Allison University, Canada. His research focuses on the behavioral pharmacology of addiction. Specifically, he is interested in how addictive substances such as nicotine and alcohol influence cue-induced craving and gambling behaviour in non-problem and pathological gamblers.
Dr. Jeffrey Anker is an Assistant Professor in the Department of Psychiatry at S.U.N.Y. Buffalo School of Medicine and Biomedical Sciences, USA. His research focuses on psycho-socio-spiritual factors related to addiction and current marijuana legalization trends in Colorado and other states.
Dr. David Jarmolowicz is an Assistant Professor in the Department of Applied Behavioral Science at the University of Kansas and also the co-Director of the Center for Applied Neuroeconomics, USA. His research focuses on deficits in neurocognitive function and behavioral economic decision making in individuals suffering from a wide range of addictive disorders.
Dr. Sabrina Des Rosiers is an Assistant Professor in the Department of Psychology, College of Arts and Sciences at Barry University, USA. Her research focuses on risk and protective factors at the individual, social, and cultural level for involvement in alcohol use, drug use. Specific areas of research include alcohol expectancies, acculturation, family functioning, prevention and implementation research.
Dr. Heberlein Annemarie is an Assistant professor in the Department of Psychiatry and Psychotherapy at Medical School Hanover, Germany. His research interest includes addiction medicine substance-related addictions (internet and computer game addiction, gambling addiction).
Dr. Ingo Willuhn is a Senior Scientist of Netherlands Institute for Neuroscience and a member of Department of Psychiatry, Academic Medical Center at University of Amsterdam, Netherlands. He lead the group of Neuromodulation and Behavior that focuses on compulsive behaviors and the therapeutic effects of deep-brain stimulation.
Dr. Jeff Lee is currently working with the Center for Public Health at Liverpool John Moores University, UK, as research officer on a European research initiative to identify a cross European drugs research agenda and as Project Manager with the European Drug Prevention Quality Standards Project. His research interests is in the field of substance abuse prevention, health promotion and education.
Dr. Ludwing Florez-Salamanca is a Research Assistant Scientist at Columbia University-New York State Psychiatric Institute, USA. His research studies are detoxification and reintegration facility in New York City and to analyze data from different national data bases to better understand mental diseases determinants and help develop interventions to improve their outcome.
Dr. Peter Nygaard is a Research Scientist at Prevention Research Center, Berkeley, California, USA. His research interest are Screening and Brief Intervention, Environmental approaches to prevention, Qualitative Methods.
Dr. Thomas Heffernan is currently working in the Department of Psychology and Faculty of Life and Health Sciences at Northumbria University, Newcastle, UK. His research focuses on cognitive consequences of recreational drug use, health and cognitive consequences of ‘binge drinking’, smoking, ecstasy and cannabis.
Dr. Raimondo Maria Pavarin is a Health Sociologist and Dependencies Epidemiologist working in the University of Bologna, Italy. His research focuses on Design and management of database and information systems on drug addictions/alcoholism, Analysis and data processing, reports, cross-sectional studies, prevalence studies, cohort studies, social and epidemiological research.
Dr. Bronwyn Kivell is currently working in the School of Biological Sciences at Victoria University of Wellington, New Zealand. Her research focuses on understanding the behavioural and cellular mechanism of action of drugs of abuse and investigating novel kappa opioid receptor compounds as potential anti-addiction pharmacotherapies.
Dr. Emma Barrett is a registered psychologist and currently working at the National Drug and Alcohol Research Centre, University of New South Wales, Australia. She has experience in the conduct of randomized controlled treatment trials andher areas of interest include substance use prevention, treatment of comorbid substance use and PTSD, and the forensic implications of comorbidity.